CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis

Author:

Gupta Vikas1ORCID,Katiyar Shobhita1,Singh Ankita1,Misra Ramnath1ORCID,Aggarwal Amita1ORCID

Affiliation:

1. Department of Clinical Immunology Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS) Lucknow Uttar Pradesh India

Funder

Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow

Publisher

Wiley

Subject

Rheumatology

Reference42 articles.

1. Consensus recommendations for the assessment and treatment of rheumatoid arthritis;Wolfe F;J Rheumatol,2001

2. 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

3. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis

4. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients;Sokka T;J Rheumatol,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3